• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心力衰竭患者肠道微生物群随衰老出现的生态失调和组成改变。

Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure.

作者信息

Kamo Takehiro, Akazawa Hiroshi, Suda Wataru, Saga-Kamo Akiko, Shimizu Yu, Yagi Hiroki, Liu Qing, Nomura Seitaro, Naito Atsuhiko T, Takeda Norifumi, Harada Mutsuo, Toko Haruhiro, Kumagai Hidetoshi, Ikeda Yuichi, Takimoto Eiki, Suzuki Jun-Ichi, Honda Kenya, Morita Hidetoshi, Hattori Masahira, Komuro Issei

机构信息

Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Graduate School of Frontier Sciences, The University of Tokyo, Kashiwa, Japan.

出版信息

PLoS One. 2017 Mar 22;12(3):e0174099. doi: 10.1371/journal.pone.0174099. eCollection 2017.

DOI:10.1371/journal.pone.0174099
PMID:28328981
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5362204/
Abstract

Emerging evidence has suggested a potential impact of gut microbiota on the pathophysiology of heart failure (HF). However, it is still unknown whether HF is associated with dysbiosis in gut microbiota. We investigated the composition of gut microbiota in patients with HF to elucidate whether gut microbial dysbiosis is associated with HF. We performed 16S ribosomal RNA gene sequencing of fecal samples obtained from 12 HF patients and 12 age-matched healthy control (HC) subjects, and analyzed the differences in gut microbiota. We further compared the composition of gut microbiota of 12 HF patients younger than 60 years of age with that of 10 HF patients 60 years of age or older. The composition of gut microbial communities of HF patients was distinct from that of HC subjects in both unweighted and weighted UniFrac analyses. Eubacterium rectale and Dorea longicatena were less abundant in the gut microbiota of HF patients than in that of HC subjects. Compared to younger HF patients, older HF patients had diminished proportions of Bacteroidetes and larger quantities of Proteobacteria. The genus Faecalibacterium was depleted, while Lactobacillus was enriched in the gut microbiota of older HF patients. These results suggest that patients with HF harbor significantly altered gut microbiota, which varies further according to age. New concept of heart-gut axis has a great potential for breakthroughs in the development of novel diagnostic and therapeutic approach for HF.

摘要

新出现的证据表明肠道微生物群对心力衰竭(HF)的病理生理学可能产生影响。然而,HF是否与肠道微生物群失调相关仍不清楚。我们调查了HF患者的肠道微生物群组成,以阐明肠道微生物失调是否与HF相关。我们对从12例HF患者和12例年龄匹配的健康对照(HC)受试者获得的粪便样本进行了16S核糖体RNA基因测序,并分析了肠道微生物群的差异。我们进一步比较了12例年龄小于60岁的HF患者与10例年龄60岁及以上的HF患者的肠道微生物群组成。在未加权和加权UniFrac分析中,HF患者的肠道微生物群落组成与HC受试者不同。直肠真杆菌和长链多尔氏菌在HF患者肠道微生物群中的丰度低于HC受试者。与年轻HF患者相比,老年HF患者拟杆菌比例降低,变形菌数量增加。在老年HF患者的肠道微生物群中,粪杆菌属减少,而乳酸杆菌属富集。这些结果表明,HF患者的肠道微生物群有显著改变,且随年龄进一步变化。心-肠轴的新概念在HF新型诊断和治疗方法的开发方面具有巨大的突破潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06c9/5362204/6a23abb08c99/pone.0174099.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06c9/5362204/2253961999a5/pone.0174099.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06c9/5362204/df18ed893e1c/pone.0174099.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06c9/5362204/a6ff40e4ee08/pone.0174099.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06c9/5362204/6a23abb08c99/pone.0174099.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06c9/5362204/2253961999a5/pone.0174099.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06c9/5362204/df18ed893e1c/pone.0174099.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06c9/5362204/a6ff40e4ee08/pone.0174099.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06c9/5362204/6a23abb08c99/pone.0174099.g004.jpg

相似文献

1
Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure.心力衰竭患者肠道微生物群随衰老出现的生态失调和组成改变。
PLoS One. 2017 Mar 22;12(3):e0174099. doi: 10.1371/journal.pone.0174099. eCollection 2017.
2
Heart failure developed after myocardial infarction does not affect gut microbiota composition in the rat.心肌梗死后心力衰竭不会影响大鼠的肠道微生物组成。
Am J Physiol Gastrointest Liver Physiol. 2019 Sep 1;317(3):G342-G348. doi: 10.1152/ajpgi.00018.2019. Epub 2019 Jul 17.
3
Dysbiosis signatures of gut microbiota in coronary artery disease.肠道微生物失调特征与冠状动脉疾病。
Physiol Genomics. 2018 Oct 1;50(10):893-903. doi: 10.1152/physiolgenomics.00070.2018. Epub 2018 Sep 7.
4
Alterations to the Gut Microbiota and Their Correlation With Inflammatory Factors in Chronic Kidney Disease.肠道微生物群的改变及其与慢性肾脏病中炎症因子的相关性。
Front Cell Infect Microbiol. 2019 Jun 12;9:206. doi: 10.3389/fcimb.2019.00206. eCollection 2019.
5
Gut Microbiota Profile Identifies Transition From Compensated Cardiac Hypertrophy to Heart Failure in Hypertensive Rats.肠道微生物群特征可识别高血压大鼠从代偿性心肌肥厚向心力衰竭的转变。
Hypertension. 2020 Nov;76(5):1545-1554. doi: 10.1161/HYPERTENSIONAHA.120.15123. Epub 2020 Sep 14.
6
Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease.中国炎症性肠病患者的粪便微生物失调。
World J Gastroenterol. 2018 Apr 7;24(13):1464-1477. doi: 10.3748/wjg.v24.i13.1464.
7
High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients.高通量 16S rRNA 基因测序揭示肌痛性脑脊髓炎/慢性疲劳综合征患者肠道微生物组的改变。
Anaerobe. 2013 Aug;22:50-6. doi: 10.1016/j.anaerobe.2013.06.002. Epub 2013 Jun 19.
8
The cardiac protection of Baoyuan decoction via gut-heart axis metabolic pathway.保元汤通过肠-心轴代谢途径对心脏的保护作用。
Phytomedicine. 2020 Dec;79:153322. doi: 10.1016/j.phymed.2020.153322. Epub 2020 Sep 2.
9
Alterations in the gut microbiota of patients with acquired immune deficiency syndrome.获得性免疫缺陷综合征患者肠道微生物组的改变。
J Cell Mol Med. 2018 Apr;22(4):2263-2271. doi: 10.1111/jcmm.13508. Epub 2018 Feb 7.
10
Gut Microbiome and Serum Metabolome Alterations Associated with Isolated Dystonia.与孤立性肌张力障碍相关的肠道微生物组和血清代谢组变化。
mSphere. 2021 Aug 25;6(4):e0028321. doi: 10.1128/mSphere.00283-21. Epub 2021 Aug 4.

引用本文的文献

1
Role of gut microbiota and derived metabolites in cardiovascular diseases.肠道微生物群及其衍生代谢产物在心血管疾病中的作用。
iScience. 2025 Jul 30;28(9):113247. doi: 10.1016/j.isci.2025.113247. eCollection 2025 Sep 19.
2
Gut microbiota's role in heart failure.肠道微生物群在心力衰竭中的作用。
Heart Fail Rev. 2025 Jul 9. doi: 10.1007/s10741-025-10543-w.
3
Mechanisms of exercise in preventing cardiovascular diseases: Insights from gut microbiota characteristics in pathological states of cardiovascular diseases.运动预防心血管疾病的机制:从心血管疾病病理状态下的肠道微生物群特征中获得的见解

本文引用的文献

1
Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome.醋酸盐介导微生物群-脑-胰岛β细胞轴以促进代谢综合征。
Nature. 2016 Jun 9;534(7606):213-7. doi: 10.1038/nature18309.
2
Gastrointestinal and Liver Issues in Heart Failure.心力衰竭中的胃肠道和肝脏问题。
Circulation. 2016 Apr 26;133(17):1696-703. doi: 10.1161/CIRCULATIONAHA.115.020894.
3
Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity.基于人群的宏基因组学分析揭示了肠道微生物组组成和多样性的标志物。
Rev Endocr Metab Disord. 2025 Jun 9. doi: 10.1007/s11154-025-09971-8.
4
Oxidative Stress, Gut Microbiota, and Extracellular Vesicles: Interconnected Pathways and Therapeutic Potentials.氧化应激、肠道微生物群与细胞外囊泡:相互关联的途径及治疗潜力
Int J Mol Sci. 2025 Mar 28;26(7):3148. doi: 10.3390/ijms26073148.
5
The Critical Role of in Cardiovascular Diseases.(原文中“in Cardiovascular Diseases”前缺少具体内容,推测可能是某个因素之类的,这里仅按现有内容翻译)……在心血管疾病中的关键作用。
Rev Cardiovasc Med. 2025 Mar 20;26(3):26740. doi: 10.31083/RCM26740. eCollection 2025 Mar.
6
Gut microbiome composition and metabolic activity in metabolic-associated fatty liver disease.代谢相关脂肪性肝病中的肠道微生物群组成与代谢活性
Virulence. 2025 Dec;16(1):2482158. doi: 10.1080/21505594.2025.2482158. Epub 2025 Mar 28.
7
Shenmai injection revives cardiac function in rats with hypertensive heart failure: involvement of microbial-host co-metabolism.参麦注射液可恢复高血压性心力衰竭大鼠的心脏功能:微生物-宿主共代谢的作用
BMC Complement Med Ther. 2025 Jan 24;25(1):24. doi: 10.1186/s12906-024-04737-2.
8
The role of the gut microbiota in the onset and progression of heart failure: insights into epigenetic mechanisms and aging.肠道微生物群在心力衰竭的发生和进展中的作用:对表观遗传机制和衰老的认识。
Clin Epigenetics. 2024 Nov 29;16(1):175. doi: 10.1186/s13148-024-01786-9.
9
Impact of Food Intake and Sleep Disturbances on Gut Microbiota.食物摄入和睡眠障碍对肠道微生物群的影响。
Cureus. 2024 Oct 4;16(10):e70846. doi: 10.7759/cureus.70846. eCollection 2024 Oct.
10
Gut Microbiota and Metabolic Alterations Associated with Heart Failure and Coronary Artery Disease.与心力衰竭和冠状动脉疾病相关的肠道微生物群和代谢改变。
Int J Mol Sci. 2024 Oct 20;25(20):11295. doi: 10.3390/ijms252011295.
Science. 2016 Apr 29;352(6285):565-9. doi: 10.1126/science.aad3369. Epub 2016 Apr 28.
4
Population-level analysis of gut microbiome variation.人群水平的肠道微生物组变异分析。
Science. 2016 Apr 29;352(6285):560-4. doi: 10.1126/science.aad3503. Epub 2016 Apr 28.
5
Brain-Gut-Bone Marrow Axis: Implications for Hypertension and Related Therapeutics.脑-肠-骨髓轴:对高血压及相关治疗的影响
Circ Res. 2016 Apr 15;118(8):1327-36. doi: 10.1161/CIRCRESAHA.116.307709.
6
The gut microbiota and metabolic disease: current understanding and future perspectives.肠道微生物群与代谢疾病:当前的认识和未来展望。
J Intern Med. 2016 Oct;280(4):339-49. doi: 10.1111/joim.12508. Epub 2016 Apr 12.
7
Signaling in Host-Associated Microbial Communities.宿主相关微生物群落中的信号传导。
Cell. 2016 Mar 10;164(6):1288-1300. doi: 10.1016/j.cell.2016.02.037.
8
Gut microbiota and aging.肠道微生物群与衰老。
Science. 2015 Dec 4;350(6265):1214-5. doi: 10.1126/science.aac8469.
9
Taking it Personally: Personalized Utilization of the Human Microbiome in Health and Disease.从个人角度出发:人类微生物组在健康和疾病中的个性化利用。
Cell Host Microbe. 2016 Jan 13;19(1):12-20. doi: 10.1016/j.chom.2015.12.016.
10
Proton pump inhibitors alter the composition of the gut microbiota.质子泵抑制剂会改变肠道微生物群的组成。
Gut. 2016 May;65(5):749-56. doi: 10.1136/gutjnl-2015-310861. Epub 2015 Dec 30.